וינדאקל
pfizer pharmaceuticals israel ltd - tafamidis as meglumine - קפסולות ג'לטין רכות - tafamidis as meglumine 12.2 mg - tafamidis
פינדין וטרינרי
intervet ( israel) ltd - flunixin as meglumine - תמיסה להזרקה - flunixin as meglumine 50 mg/ml
פלוניקסין תמיסה להזרקה קומקס וטרינרי
comex ltd - flunixin as meglumine - תמיסה להזרקה - flunixin as meglumine 50 mg/ml
טלבריקס 35
promedico ltd - meglumine ioxitalamate; sodium ioxitalamate - תמיסה להזרקה - sodium ioxitalamate 9.66 %; meglumine ioxitalamate 65.09 % - ioxitalamic acid - ioxitalamic acid - angiocardiography (ventriculography - coronary angiography) - digital substraction angiography - computerized tomography- intravenous urography.
טלבריקס 35
promedico ltd - meglumine ioxitalamate; sodium ioxitalamate - תמיסה להזרקה - sodium ioxitalamate 9.66 %; meglumine ioxitalamate 65.09 % - ioxitalamic acid
מגנטול
isotopia molecular imaging, israel - gadopentetic acid dimeglumine - תמיסה להזרקה - gadopentetic acid dimeglumine 469 mg/ml - gadopentetic acid - gadopentetic acid - injectable contrast medium for magnetic resonance imaging (mri).
מלטיהנס
dexcel ltd, israel - gadobenic acid as dimeglumine salt - תמיסה להזרקה - gadobenic acid as dimeglumine salt 334 mg/ml - gadobenic acid - gadobenic acid - multihance is a paramagnetic contrast agent for use in diagnostic magnetic resonance imaging (mri) indicated for: • mri of the liver for the detection of focal liver lesions in patients with known or suspected primary liver cancer (eg. hepatocellular carcinoma) or metastatic disease.• mri of the brain and spine where it improves the detection of lesions and provides diagnostic information additional to that obtained with unenhanced mri.• contrast-enhanced mr- angiography where it improves the diagnostic accuracy for detecting clinically significant steno-occlusive vascular disease in patients with suspected or known vascular disease of the abdominal or peripheral arteries.
ניגלומין וטרינרי
mip veterinaria ltd - flunixin as meglumine - תמיסה להזרקה - flunixin as meglumine 50 mg/ml
מגניל 50 מגמל וטרינרי
m.p.vet ltd - flunixin as meglumine - תמיסה להזרקה - flunixin as meglumine 50 mg/ml
אימנד 150 מ"ג iv
merck sharp & dohme israel ltd - fosaprepitant as fosaprepitant dimeglumine 150 mg - powder for solution for infusion - aprepitant - emend iv 150mg in combination with other antiemetic agents is indicated for the: - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose cisplatin. - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.